InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Explore the detailed record of transactions filed by Maier Paul V. Director active across 2 companies, notably Ambrx Biopharma Inc.. Cumulatively, 5 reports have been published. Breakdown: 0 buy · 3 sells. Total volume traded: €2.5m. Activity tracked since 7 June 2023. The latest transaction was disclosed on 28 August 2026 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations